Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
BRCA1 or BRCA2
.
Show all posts
Showing posts with label
BRCA1 or BRCA2
.
Show all posts
Saturday, March 31, 2012
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer — NEJM
›
We know that Olaparib , is a experimental chemotherapeutic agent , developed by KuDOS Pharmaceuticals and later by Astra Zeneca , t...
1 comment:
›
Home
View web version
